CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS (Unaudited) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2012	Mar. 26, 2011
CASH FLOWS FROM OPERATING ACTIVITIES:
Net earnings (loss) attributable to controlling interest	$ 4,155	$ (3,670)
Adjustments to reconcile net earnings (loss) attributable to controlling interest to net cash from operating activities:
Depreciation	7,178	6,902
Amortization of intangibles	745	1,441
Expense associated with share-based compensation arrangements	504	875
Excess tax benefits from share-based compensation arrangements	(12)	(121)
Deferred income tax credit	(50)	(69)
Net earnings attributable to noncontrolling interest	231	258
Equity in earnings of investee	(62)	(17)
Net loss on sale or impairment of property, plant and equipment	(25)	(142)
Changes in:
Accounts receivable	(64,829)	(55,869)
Inventories	(23,392)	(53,007)
Accounts payable	25,585	7,035
Accrued liabilities and other	5,327	(13,095)
NET CASH FROM OPERATING ACTIVITIES	(44,645)	(109,479)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of property, plant and equipment	(7,860)	(6,309)
Proceeds from sale of property, plant and equipment	2,035	177
Purchase of patents	(21)	0
Collections of notes receivable	647	243
Other, net	(302)	25
NET CASH FROM INVESTING ACTIVITIES	(5,501)	(5,864)
CASH FLOWS FROM FINANCING ACTIVITIES:
Net borrowings under revolving credit facilities	33,968	71,817
Debt issuance costs	(81)	0
Proceeds from issuance of common stock	1,036	456
Purchase of additional noncontrolling interest	0	(100)
Distributions to noncontrolling interest	(379)	(395)
Capital contribution from noncontrolling interest	0	40
Excess tax benefits from share-based compensation arrangements	12	121
Other, net	3	0
NET CASH FROM FINANCING ACTIVITIES	34,559	71,939
NET CHANGE IN CASH AND CASH EQUIVALENTS	(15,587)	(43,404)
CASH AND CASH EQUIVALENTS, BEGINNING OF YEAR	11,305	43,363
CASH OVERDRAFT END OF PERIOD	(4,282)	(41)
Cash paid during the period for:
Interest	261	250
Income taxes	3,400	1,690
NON-CASH FINANCING ACTIVITIES:
Common stock issued under deferred compensation plans	$ 851	$ 109